Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Trinity Biotech plc

TRIBβ€’NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.74
$0.03(4.38%)
U.S. Market opens in NaNh NaNm

TRIB News Today: Stay Updated with the Latest Trinity Biotech plc News in Real Time

Find TRIB news now at Meyka AI. Stay informed with the latest Trinity Biotech plc stocks updates, including price news, market analysis, and expert insights.

Intraday 24 Feb 2026: IHL.AX stock down 10.87% to A$0.041 on 61.36M volume: active traders eye catalysts
πŸ“… in about 1 hour

Intraday 24 Feb 2026: IHL.AX stock down 10.87% to A$0.041 on 61.36M volume: active traders eye catalysts

IHL.AX stock slips to A$0.041 on heavy volume; intraday analysis, grade and A$0.09 forecast for traders

Read more
Pre-market 24 Feb 2026: SK3.IR Smurfit Kappa (EURONEXT) at EUR 41.44, rising volume signals active trade
πŸ“… in about 1 hour

Pre-market 24 Feb 2026: SK3.IR Smurfit Kappa (EURONEXT) at EUR 41.44, rising volume signals active trade

SK3.IR stock pre-market: EUR 41.44, heavy volume and Meyka AI outlook with price targets

Read more
Pre-market 24 Feb 2026: IDIA.SW Idorsia Ltd (SIX) earnings due Feb 26, watch CHF3.87 catalyst
πŸ“… in 41 minutes

Pre-market 24 Feb 2026: IDIA.SW Idorsia Ltd (SIX) earnings due Feb 26, watch CHF3.87 catalyst

Pre-market look at IDIA.SW stock ahead of Feb 26 earnings. Price CHF3.87, Meyka AI forecast CHF5.43 and model targets

Read more
FTI.PA stock: TechnipFMC pre-market most active 24 Feb 2026, heavy volume
πŸ“… in 14 minutes

FTI.PA stock: TechnipFMC pre-market most active 24 Feb 2026, heavy volume

Pre-market update: FTI.PA stock at €5.91 with heavy volume; grade, valuation and model forecast included

Read more
February 24: Takaichi Cabinet 2.0 Backs Drug Investment, Biosimilar Parity
πŸ“… 2 hours ago

February 24: Takaichi Cabinet 2.0 Backs Drug Investment, Biosimilar Parity

Takaichi Cabinet 2.0 backs public-private drug R&D and extends Japan drug pricing reform 2026 to biologics via the G1 rule, moving originator prices toward biosimilar parity. What it means for Japan’s

Read more
OCX OncoCyte NASDAQ After Hours 23 Feb 2026: $3.20 oversold bounce, watch $3.80
πŸ“… 2 hours ago

OCX OncoCyte NASDAQ After Hours 23 Feb 2026: $3.20 oversold bounce, watch $3.80

OCX stock rises to $3.20 after hours on 23 Feb 2026 after an oversold bounce; analysis, price targets and risks for NASDAQ-listed OncoCyte

Read more
Volume spike: ID25.SW iShares V PLC SIX CHF111.78 Feb 2026, monitor liquidity
πŸ“… 2 hours ago

Volume spike: ID25.SW iShares V PLC SIX CHF111.78 Feb 2026, monitor liquidity

ID25.SW stock saw a volume spike to **4,500** shares at **CHF111.78** on SIX; we analyse liquidity, technicals and Meyka AI forecasts

Read more
PRE-MARKET TOP LOSERS: PRISM BioLab (206A.T) down Β₯7.69 on JPX: earnings watch
πŸ“… 3 hours ago

PRE-MARKET TOP LOSERS: PRISM BioLab (206A.T) down Β₯7.69 on JPX: earnings watch

206A.T stock falls pre-market to Β₯221.00 on JPX; analyst and technical setup suggest cautious outlook

Read more
3LPA.PA up 5.83% to €844.79 at EURONEXT close 23 Feb 2026: watch volatility
πŸ“… 4 hours ago

3LPA.PA up 5.83% to €844.79 at EURONEXT close 23 Feb 2026: watch volatility

EURONEXT close: 3LPA.PA stock up 5.83% to €844.79 on 23 Feb 2026; short-term momentum and forecast analysis

Read more

TRIB News FAQ